Anteris Technologies Global Corp.’s AVR share price has dipped by 7.04%, which has investors questioning if this is right ...

Onchilles Pharma, a private biotech company pioneering next-generation cytotoxic therapeutics that harness the ELANE pathway, today announced the presentation of new preclinical data for its lead drug ...

Anteris Technologies Global Corp.’s AVR share price has surged by 12.25%, which has investors questioning if this is right time to sell.

These results demonstrate that the axis of interleukin 12 and gamma interferon provides a survival advantage in vascularized xenografts by delaying or preventing acute vascular rejection caused by ...

Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, ...

State Key Laboratory of Anti-Infective Drug Discovery and Development, Sun Yat-sen University, Guangzhou 510006, China Guangdong Provincial Key Laboratory of Chiral Molecules and Drug Discovery, ...

In an AR-expressing patient-derived xenograft mouse model, bavdegalutamide showed substantial AR degradation and greater tumor growth inhibition compared with enzalutamide. Bavdegalutamide also showed ...

Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. It operates through the following ...

For most people, the Denon AVR-X1800H offers everything necessary—now and for the foreseeable future—to enjoy a premium movie, video game, TV, or music experience with full immersive-sound ...